Tomoko Iwata Selected Research

N2-ethyl-2'-deoxyguanosine

1/2018

Progress in a selective method for the determination of the acetaldehyde-derived DNA adducts by using HILIC-ESI-MS/MS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomoko Iwata Research Topics

Disease

9	Heart Failure 10/2022 - 01/2021
6	Neoplasms (Cancer) 01/2020 - 10/2005
3	Carcinogenesis 01/2018 - 07/2011
2	Urinary Bladder Neoplasms (Bladder Cancer) 11/2018 - 06/2014
2	Communicable Diseases (Infectious Diseases) 01/2017 - 01/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Atrial Fibrillation 01/2021
1	Disease Progression 01/2021
1	Inflammation (Inflammations) 11/2018
1	Carcinoma (Carcinomatosis) 07/2011
1	Papilloma (Papillomatosis) 07/2011
1	Neuroblastoma 11/2010
1	Melanoma (Melanoma, Malignant) 07/2006
1	Achondroplasia 01/2004

Drug/Important Bio-Agent (IBA)

7	empagliflozinIBA 01/2022 - 01/2021
4	Troponin T (Troponin T1)IBA 10/2022 - 01/2021
4	pro-brain natriuretic peptide (1-76)IBA 10/2022 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2020
4	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2022 - 01/2021
3	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 06/2014 - 01/2004
2	Sodium-Glucose Transport ProteinsIBA 11/2021 - 01/2021
2	Natriuretic PeptidesIBA 01/2021 - 01/2021
2	VaccinesIBA 01/2017 - 01/2015
1	AlbuminsIBA 10/2022
1	Insulin (Novolin)FDA Link 10/2022
1	Neprilysin (Neutral Endopeptidase)IBA 11/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 11/2021
1	DiureticsIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	TroponinIBA 01/2021
1	Circulating Tumor DNAIBA 01/2020
1	CarcinogensIBA 11/2018
1	Monoclonal AntibodiesIBA 11/2018
1	hydroxide ionIBA 11/2018
1	Phenobarbital (Luminal)FDA Link 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	N2-ethyl-2'-deoxyguanosineIBA 01/2018
1	Liposomes (Liposome)IBA 01/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2012
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 04/2012
1	CateninsIBA 07/2011
1	Cre recombinaseIBA 07/2011
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 11/2010
1	Small Interfering RNA (siRNA)IBA 11/2010
1	AntigensIBA 01/2008
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2008
1	U 0126 (UO 126)IBA 07/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2006
1	Interleukin-6 (Interleukin 6)IBA 07/2006
1	CytokinesIBA 07/2006
1	Interleukin-12 (IL 12)IBA 07/2006
1	LipopolysaccharidesIBA 07/2006
1	InterleukinsIBA 07/2006
1	Mitogen-Activated Protein KinasesIBA 07/2006
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2006
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2005

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2020
1	Immunotherapy 01/2008